The global Intravenous Injection General Anesthesia Drugs market was valued at 1635 million in 2024 and is projected to reach US$ 2566 million by 2031, at a CAGR of 6.8% during the forecast period.
Intravenous general anesthesia refers to a method in which one or several drugs are injected intravenously and act on the central nervous system through blood circulation to produce general anesthesia. According to different administration methods, intravenous anesthesia can be divided into single administration method, divided administration method and continuous administration method. Due to some limitations of its own, the use of intravenous general anesthesia was once limited. However, since the 1980s, with the continuous improvement of clinical pharmacology research methods, the development of new strong and short-acting intravenous anesthetics and the advent of computerized intravenous automatic drug delivery systems, intravenous anesthesia has been greatly improved. And development, has now become the mainstream general anesthesia solution.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intravenous Injection General Anesthesia Drugs manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Intravenous Injection General Anesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Injection General Anesthesia Drugs. This report contains market size and forecasts of Intravenous Injection General Anesthesia Drugs in global, including the following market information:
Global Intravenous Injection General Anesthesia Drugs market revenue, 2020-2025, 2026-2031, ($ millions)
Global Intravenous Injection General Anesthesia Drugs market sales, 2020-2025, 2026-2031, (K Units)
Global top five Intravenous Injection General Anesthesia Drugs companies in 2024 (%)
Total Market by Segment:
Global Intravenous Injection General Anesthesia Drugs market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Intravenous Injection General Anesthesia Drugs market segment percentages, by Type, 2024 (%)
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Global Intravenous Injection General Anesthesia Drugs market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Intravenous Injection General Anesthesia Drugs market segment percentages, by Application, 2024 (%)
Hopitals
Clinics
Others
Global Intravenous Injection General Anesthesia Drugs market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Intravenous Injection General Anesthesia Drugs market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravenous Injection General Anesthesia Drugs revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Intravenous Injection General Anesthesia Drugs revenues share in global market, 2024 (%)
Key companies Intravenous Injection General Anesthesia Drugs sales in global market, 2020-2025 (estimated), (K Units)
Key companies Intravenous Injection General Anesthesia Drugs sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
AstraZeneca
Nhwa
Hengrui
Xian Libang
Yichang Humanwell
China National Medicines Guorui Pharmaceutical Co.,Ltd.
Maruishi
Lunan Pharmaceutical Group Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intravenous Injection General Anesthesia Drugs, market overview.
Chapter 2: Global Intravenous Injection General Anesthesia Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Intravenous Injection General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intravenous Injection General Anesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Intravenous Injection General Anesthesia Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Intravenous Injection General Anesthesia Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Intravenous Injection General Anesthesia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intravenous Injection General Anesthesia Drugs Overall Market Size
2.1 Global Intravenous Injection General Anesthesia Drugs Market Size: 2024 VS 2031
2.2 Global Intravenous Injection General Anesthesia Drugs Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Intravenous Injection General Anesthesia Drugs Sales: 2020-2031
3 Company Landscape
3.1 Top Intravenous Injection General Anesthesia Drugs Players in Global Market
3.2 Top Global Intravenous Injection General Anesthesia Drugs Companies Ranked by Revenue
3.3 Global Intravenous Injection General Anesthesia Drugs Revenue by Companies
3.4 Global Intravenous Injection General Anesthesia Drugs Sales by Companies
3.5 Global Intravenous Injection General Anesthesia Drugs Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Intravenous Injection General Anesthesia Drugs Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Intravenous Injection General Anesthesia Drugs Product Type
3.8 Tier 1, Tier 2, and Tier 3 Intravenous Injection General Anesthesia Drugs Players in Global Market
3.8.1 List of Global Tier 1 Intravenous Injection General Anesthesia Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Intravenous Injection General Anesthesia Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Intravenous Injection General Anesthesia Drugs Market Size Markets, 2024 & 2031
4.1.2 Propofol
4.1.3 Sevoflurane
4.1.4 Remifentanil
4.1.5 Etomidate
4.1.6 Isoflurane
4.1.7 Other
4.2 Segment by Type - Global Intravenous Injection General Anesthesia Drugs Revenue & Forecasts
4.2.1 Segment by Type - Global Intravenous Injection General Anesthesia Drugs Revenue, 2020-2025
4.2.2 Segment by Type - Global Intravenous Injection General Anesthesia Drugs Revenue, 2026-2031
4.2.3 Segment by Type - Global Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Intravenous Injection General Anesthesia Drugs Sales & Forecasts
4.3.1 Segment by Type - Global Intravenous Injection General Anesthesia Drugs Sales, 2020-2025
4.3.2 Segment by Type - Global Intravenous Injection General Anesthesia Drugs Sales, 2026-2031
4.3.3 Segment by Type - Global Intravenous Injection General Anesthesia Drugs Sales Market Share, 2020-2031
4.4 Segment by Type - Global Intravenous Injection General Anesthesia Drugs Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Intravenous Injection General Anesthesia Drugs Market Size, 2024 & 2031
5.1.2 Hopitals
5.1.3 Clinics
5.1.4 Others
5.2 Segment by Application - Global Intravenous Injection General Anesthesia Drugs Revenue & Forecasts
5.2.1 Segment by Application - Global Intravenous Injection General Anesthesia Drugs Revenue, 2020-2025
5.2.2 Segment by Application - Global Intravenous Injection General Anesthesia Drugs Revenue, 2026-2031
5.2.3 Segment by Application - Global Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Intravenous Injection General Anesthesia Drugs Sales & Forecasts
5.3.1 Segment by Application - Global Intravenous Injection General Anesthesia Drugs Sales, 2020-2025
5.3.2 Segment by Application - Global Intravenous Injection General Anesthesia Drugs Sales, 2026-2031
5.3.3 Segment by Application - Global Intravenous Injection General Anesthesia Drugs Sales Market Share, 2020-2031
5.4 Segment by Application - Global Intravenous Injection General Anesthesia Drugs Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Intravenous Injection General Anesthesia Drugs Market Size, 2024 & 2031
6.2 By Region - Global Intravenous Injection General Anesthesia Drugs Revenue & Forecasts
6.2.1 By Region - Global Intravenous Injection General Anesthesia Drugs Revenue, 2020-2025
6.2.2 By Region - Global Intravenous Injection General Anesthesia Drugs Revenue, 2026-2031
6.2.3 By Region - Global Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020-2031
6.3 By Region - Global Intravenous Injection General Anesthesia Drugs Sales & Forecasts
6.3.1 By Region - Global Intravenous Injection General Anesthesia Drugs Sales, 2020-2025
6.3.2 By Region - Global Intravenous Injection General Anesthesia Drugs Sales, 2026-2031
6.3.3 By Region - Global Intravenous Injection General Anesthesia Drugs Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Intravenous Injection General Anesthesia Drugs Revenue, 2020-2031
6.4.2 By Country - North America Intravenous Injection General Anesthesia Drugs Sales, 2020-2031
6.4.3 United States Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.4.4 Canada Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.4.5 Mexico Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Intravenous Injection General Anesthesia Drugs Revenue, 2020-2031
6.5.2 By Country - Europe Intravenous Injection General Anesthesia Drugs Sales, 2020-2031
6.5.3 Germany Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.5.4 France Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.5.5 U.K. Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.5.6 Italy Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.5.7 Russia Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.5.8 Nordic Countries Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.5.9 Benelux Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Intravenous Injection General Anesthesia Drugs Revenue, 2020-2031
6.6.2 By Region - Asia Intravenous Injection General Anesthesia Drugs Sales, 2020-2031
6.6.3 China Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.6.4 Japan Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.6.5 South Korea Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.6.6 Southeast Asia Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.6.7 India Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Intravenous Injection General Anesthesia Drugs Revenue, 2020-2031
6.7.2 By Country - South America Intravenous Injection General Anesthesia Drugs Sales, 2020-2031
6.7.3 Brazil Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.7.4 Argentina Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Intravenous Injection General Anesthesia Drugs Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales, 2020-2031
6.8.3 Turkey Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.8.4 Israel Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.8.5 Saudi Arabia Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
6.8.6 UAE Intravenous Injection General Anesthesia Drugs Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Aspen Pharma
7.1.1 Aspen Pharma Company Summary
7.1.2 Aspen Pharma Business Overview
7.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.1.4 Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.1.5 Aspen Pharma Key News & Latest Developments
7.2 Fresenius-Kabi
7.2.1 Fresenius-Kabi Company Summary
7.2.2 Fresenius-Kabi Business Overview
7.2.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.2.4 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.2.5 Fresenius-Kabi Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.3.4 AbbVie Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.3.5 AbbVie Key News & Latest Developments
7.4 Baxter Healthcare
7.4.1 Baxter Healthcare Company Summary
7.4.2 Baxter Healthcare Business Overview
7.4.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.4.4 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.4.5 Baxter Healthcare Key News & Latest Developments
7.5 B.Braun
7.5.1 B.Braun Company Summary
7.5.2 B.Braun Business Overview
7.5.3 B.Braun Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.5.4 B.Braun Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.5.5 B.Braun Key News & Latest Developments
7.6 Maruishi
7.6.1 Maruishi Company Summary
7.6.2 Maruishi Business Overview
7.6.3 Maruishi Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.6.4 Maruishi Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.6.5 Maruishi Key News & Latest Developments
7.7 Piramal
7.7.1 Piramal Company Summary
7.7.2 Piramal Business Overview
7.7.3 Piramal Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.7.4 Piramal Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.7.5 Piramal Key News & Latest Developments
7.8 Hikma Pharmaceuticals
7.8.1 Hikma Pharmaceuticals Company Summary
7.8.2 Hikma Pharmaceuticals Business Overview
7.8.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.8.4 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.8.5 Hikma Pharmaceuticals Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.9.4 AstraZeneca Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Nhwa
7.10.1 Nhwa Company Summary
7.10.2 Nhwa Business Overview
7.10.3 Nhwa Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.10.4 Nhwa Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.10.5 Nhwa Key News & Latest Developments
7.11 Hengrui
7.11.1 Hengrui Company Summary
7.11.2 Hengrui Business Overview
7.11.3 Hengrui Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.11.4 Hengrui Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.11.5 Hengrui Key News & Latest Developments
7.12 Xian Libang
7.12.1 Xian Libang Company Summary
7.12.2 Xian Libang Business Overview
7.12.3 Xian Libang Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.12.4 Xian Libang Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.12.5 Xian Libang Key News & Latest Developments
7.13 Yichang Humanwell
7.13.1 Yichang Humanwell Company Summary
7.13.2 Yichang Humanwell Business Overview
7.13.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.13.4 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.13.5 Yichang Humanwell Key News & Latest Developments
7.14 China National Medicines Guorui Pharmaceutical Co.,Ltd.
7.14.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Summary
7.14.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
7.14.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.14.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.14.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.15 Maruishi
7.15.1 Maruishi Company Summary
7.15.2 Maruishi Business Overview
7.15.3 Maruishi Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.15.4 Maruishi Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.15.5 Maruishi Key News & Latest Developments
7.16 Lunan Pharmaceutical Group Corporation
7.16.1 Lunan Pharmaceutical Group Corporation Company Summary
7.16.2 Lunan Pharmaceutical Group Corporation Business Overview
7.16.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Major Product Offerings
7.16.4 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales and Revenue in Global (2020-2025)
7.16.5 Lunan Pharmaceutical Group Corporation Key News & Latest Developments
8 Global Intravenous Injection General Anesthesia Drugs Production Capacity, Analysis
8.1 Global Intravenous Injection General Anesthesia Drugs Production Capacity, 2020-2031
8.2 Intravenous Injection General Anesthesia Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Intravenous Injection General Anesthesia Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Intravenous Injection General Anesthesia Drugs Supply Chain Analysis
10.1 Intravenous Injection General Anesthesia Drugs Industry Value Chain
10.2 Intravenous Injection General Anesthesia Drugs Upstream Market
10.3 Intravenous Injection General Anesthesia Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Intravenous Injection General Anesthesia Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Intravenous Injection General Anesthesia Drugs in Global Market
Table 2. Top Intravenous Injection General Anesthesia Drugs Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Intravenous Injection General Anesthesia Drugs Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Intravenous Injection General Anesthesia Drugs Revenue Share by Companies, 2020-2025
Table 5. Global Intravenous Injection General Anesthesia Drugs Sales by Companies, (K Units), 2020-2025
Table 6. Global Intravenous Injection General Anesthesia Drugs Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Intravenous Injection General Anesthesia Drugs Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Intravenous Injection General Anesthesia Drugs Product Type
Table 9. List of Global Tier 1 Intravenous Injection General Anesthesia Drugs Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intravenous Injection General Anesthesia Drugs Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Intravenous Injection General Anesthesia Drugs Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Intravenous Injection General Anesthesia Drugs Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Intravenous Injection General Anesthesia Drugs Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Intravenous Injection General Anesthesia Drugs Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2026-2031
Table 21. By Region – Global Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2020-2025
Table 25. By Region - Global Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2026-2031
Table 26. By Country - North America Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2020-2025
Table 29. By Country - North America Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2026-2031
Table 30. By Country - Europe Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2020-2025
Table 33. By Country - Europe Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2026-2031
Table 34. By Region - Asia Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2020-2025
Table 37. By Region - Asia Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2026-2031
Table 38. By Country - South America Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2020-2025
Table 41. By Country - South America Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales, (K Units), 2026-2031
Table 46. Aspen Pharma Company Summary
Table 47. Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Offerings
Table 48. Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Aspen Pharma Key News & Latest Developments
Table 50. Fresenius-Kabi Company Summary
Table 51. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Offerings
Table 52. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Fresenius-Kabi Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Intravenous Injection General Anesthesia Drugs Product Offerings
Table 56. AbbVie Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. AbbVie Key News & Latest Developments
Table 58. Baxter Healthcare Company Summary
Table 59. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Offerings
Table 60. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Baxter Healthcare Key News & Latest Developments
Table 62. B.Braun Company Summary
Table 63. B.Braun Intravenous Injection General Anesthesia Drugs Product Offerings
Table 64. B.Braun Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. B.Braun Key News & Latest Developments
Table 66. Maruishi Company Summary
Table 67. Maruishi Intravenous Injection General Anesthesia Drugs Product Offerings
Table 68. Maruishi Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Maruishi Key News & Latest Developments
Table 70. Piramal Company Summary
Table 71. Piramal Intravenous Injection General Anesthesia Drugs Product Offerings
Table 72. Piramal Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Piramal Key News & Latest Developments
Table 74. Hikma Pharmaceuticals Company Summary
Table 75. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Offerings
Table 76. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Hikma Pharmaceuticals Key News & Latest Developments
Table 78. AstraZeneca Company Summary
Table 79. AstraZeneca Intravenous Injection General Anesthesia Drugs Product Offerings
Table 80. AstraZeneca Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. AstraZeneca Key News & Latest Developments
Table 82. Nhwa Company Summary
Table 83. Nhwa Intravenous Injection General Anesthesia Drugs Product Offerings
Table 84. Nhwa Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Nhwa Key News & Latest Developments
Table 86. Hengrui Company Summary
Table 87. Hengrui Intravenous Injection General Anesthesia Drugs Product Offerings
Table 88. Hengrui Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Hengrui Key News & Latest Developments
Table 90. Xian Libang Company Summary
Table 91. Xian Libang Intravenous Injection General Anesthesia Drugs Product Offerings
Table 92. Xian Libang Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Xian Libang Key News & Latest Developments
Table 94. Yichang Humanwell Company Summary
Table 95. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Offerings
Table 96. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Yichang Humanwell Key News & Latest Developments
Table 98. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Summary
Table 99. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Offerings
Table 100. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. China National Medicines Guorui Pharmaceutical Co.,Ltd. Key News & Latest Developments
Table 102. Maruishi Company Summary
Table 103. Maruishi Intravenous Injection General Anesthesia Drugs Product Offerings
Table 104. Maruishi Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Maruishi Key News & Latest Developments
Table 106. Lunan Pharmaceutical Group Corporation Company Summary
Table 107. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Offerings
Table 108. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. Lunan Pharmaceutical Group Corporation Key News & Latest Developments
Table 110. Intravenous Injection General Anesthesia Drugs Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 111. Global Intravenous Injection General Anesthesia Drugs Capacity Market Share of Key Manufacturers, 2023-2025
Table 112. Global Intravenous Injection General Anesthesia Drugs Production by Region, 2020-2025 (K Units)
Table 113. Global Intravenous Injection General Anesthesia Drugs Production by Region, 2026-2031 (K Units)
Table 114. Intravenous Injection General Anesthesia Drugs Market Opportunities & Trends in Global Market
Table 115. Intravenous Injection General Anesthesia Drugs Market Drivers in Global Market
Table 116. Intravenous Injection General Anesthesia Drugs Market Restraints in Global Market
Table 117. Intravenous Injection General Anesthesia Drugs Raw Materials
Table 118. Intravenous Injection General Anesthesia Drugs Raw Materials Suppliers in Global Market
Table 119. Typical Intravenous Injection General Anesthesia Drugs Downstream
Table 120. Intravenous Injection General Anesthesia Drugs Downstream Clients in Global Market
Table 121. Intravenous Injection General Anesthesia Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Intravenous Injection General Anesthesia Drugs Product Picture
Figure 2. Intravenous Injection General Anesthesia Drugs Segment by Type in 2024
Figure 3. Intravenous Injection General Anesthesia Drugs Segment by Application in 2024
Figure 4. Global Intravenous Injection General Anesthesia Drugs Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Intravenous Injection General Anesthesia Drugs Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Intravenous Injection General Anesthesia Drugs Revenue: 2020-2031 (US$, Mn)
Figure 8. Intravenous Injection General Anesthesia Drugs Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Intravenous Injection General Anesthesia Drugs Revenue in 2024
Figure 10. Segment by Type – Global Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Intravenous Injection General Anesthesia Drugs Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Intravenous Injection General Anesthesia Drugs Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Intravenous Injection General Anesthesia Drugs Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Intravenous Injection General Anesthesia Drugs Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020-2031
Figure 21. By Region - Global Intravenous Injection General Anesthesia Drugs Sales Market Share, 2020-2031
Figure 22. By Country - North America Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020-2031
Figure 23. By Country - North America Intravenous Injection General Anesthesia Drugs Sales Market Share, 2020-2031
Figure 24. United States Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Intravenous Injection General Anesthesia Drugs Sales Market Share, 2020-2031
Figure 29. Germany Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 30. France Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Intravenous Injection General Anesthesia Drugs Sales Market Share, 2020-2031
Figure 38. China Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 42. India Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Intravenous Injection General Anesthesia Drugs Revenue Market Share, 2020-2031
Figure 44. By Country - South America Intravenous Injection General Anesthesia Drugs Sales, Market Share, 2020-2031
Figure 45. Brazil Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Intravenous Injection General Anesthesia Drugs Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales, Market Share, 2020-2031
Figure 49. Turkey Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Intravenous Injection General Anesthesia Drugs Revenue, (US$, Mn), 2020-2031
Figure 53. Global Intravenous Injection General Anesthesia Drugs Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Intravenous Injection General Anesthesia Drugs by Region, 2024 VS 2031
Figure 55. Intravenous Injection General Anesthesia Drugs Industry Value Chain
Figure 56. Marketing Channels
